Elite Pharmaceuticals INC /Nv
OTC: ELTPNorthvale, US · New Jersey corporation
Founders & leadership
DP
Douglas PlasscheExecutive
CW
Carter WardExecutive
NH
Nasrat HakimExecutive
AN
Ashok NigalayeExecutive
Board
JT
Jerry TreppelBoard director
JN
Jeenarine NarineBoard director
DC
Davis CaskeyBoard director
EP
Eugene PfeiferBoard director
BD
Barry DashBoard director
JW
Jeffrey WhitnellBoard director
Reported raises · per SEC filings
Form D private placements$2.1M disclosed across 3 rounds · 2014–2020
▶$500KraisedJul 2020 · 1 investors · PharmaceuticalsRule 506(b)
▶$500KraisedJul 2020 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Carter WardExecutive Officer
- Douglas PlasscheExecutive Officer
- Barry DashDirector
- Nasrat HakimExecutive Officer, Director
- Davis CaskeyDirector
- Jeffrey WhitnellDirector
- Offering amount
- $26M
- Amount sold
- $500K
- Minimum investment
- $1
- First sale
- Jul 2020
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$800KraisedMay 2017 · 1 investors · PharmaceuticalsRule 506(b)
▶$800KraisedMay 2017 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Davis CaskeyDirector
- Douglas PlasscheExecutive Officer
- Eugene PfeiferDirector
- Carter WardExecutive Officer
- Nasrat HakimExecutive Officer, Director
- Barry DashDirector
- Jeffrey WhitnellDirector
- Offering amount
- $41.6M
- Amount sold
- $800K
- Minimum investment
- $1
- First sale
- May 2017
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$800KraisedApr 2014 · 1 investors · PharmaceuticalsRule 506(b)
▶$800KraisedApr 2014 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Barry DashDirector
- Jerry TreppelDirector
- Carter WardExecutive Officer
- Jeffrey WhitnellDirector
- Ashok NigalayeExecutive Officer, Director
- Jeenarine NarineDirector
- Nasrat HakimExecutive Officer, Director
- Offering amount
- $41.6M
- Amount sold
- $800K
- First sale
- Apr 2014
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Elite Pharmaceuticals INC /Nv raised?
- Elite Pharmaceuticals INC /Nv has disclosed $2.1M raised across 3 rounds.
- Where is Elite Pharmaceuticals INC /Nv headquartered?
- Elite Pharmaceuticals INC /Nv is headquartered in Northvale, US.